SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant downward pressure as disappointing delivery figures for the first quarter highlight growing concerns over demand and inventory buildup. The community remains deeply divided, with bears pointing to slowing EV sales and fading brand sentiment, while bulls continue to pivot the narrative toward the company's long-term ambitions in AI, robotics, and the potential impact of a future SpaceX IPO.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors weigh an earnings beat against concerns over leadership performance and persistent share price volatility. The community remains divided, with bulls pointing to the company's international growth and potential regulatory catalysts, while bears highlight ongoing cash burn, management frustrations, and a lack of clear federal progress.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing heightened market activity driven by reports of potential acquisition interest from major tech players like Amazon, sparking intense community debate over its strategic value in the burgeoning satellite-to-device connectivity market. Investors are actively discussing the implications of a bidding war, the critical nature of its licensed spectrum, and the potential impact of its existing partnerships on a possible buyout.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing intense market activity as investors weigh its inclusion in the S&P 500 against concerns over its rapid share price appreciation and high valuation. While the community remains deeply divided between bulls citing AI infrastructure tailwinds and bears warning of a potential bubble, sentiment is currently driven by heavy options flow and anticipation of forced institutional buying.

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Professional and Industrial, Science, Engineering, and Technology, Education, Outsourcing and Consulting, and International. The Professional and Industrial segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The Science, Engineering, and Technology segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment involves offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The Outsourcing and Consulting segment consists of global talent supply chain and workforce solutions, including Managed Service Provider (MSP), Recruitment Process Outsourcing (RPO), Payroll Process Outsourcing (PPO), and executive coaching programs. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class B

KELYB is seeing intense community debate over its volatility and low-float structure, with bulls pointing to high institutional accumulation and potential squeeze scenarios while bears warn of extreme manipulation and risks after recent sharp price swings. Investors are closely watching for updates on the company's long-term strategy, specifically seeking clarity on how new ownership plans to unlock value from the firm's significant revenue base.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently under intense scrutiny as investors debate whether recent network-related security incidents and market volatility present a buying opportunity or a signal of deeper structural weakness. While some in the community remain focused on developer momentum and potential institutional adoption through emerging clarity in stablecoin regulation, others express caution due to ongoing concerns about crypto-wide liquidity and the risks associated with altcoin exposure.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as the market anticipates the impact of its recently launched drug YARTEMLEA and ongoing developments surrounding a multi-billion dollar partnership with Novo Nordisk. Investors are closely tracking the company's progress on drug distribution, potential near-term milestone payments, and speculative buyout interest, while the community remains divided over short-term price volatility versus the stock's long-term growth potential.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is currently trending as investors speculate on its potential for a regulatory rebound following a previous FDA complete response letter (CRL) for its RP1 treatment in advanced melanoma. The community is heavily divided, with intense debate centered on the upcoming Type A meeting, the potential for an expedited path forward despite high hurdles, and significant high-risk activity in the options market as traders weigh the binary outcome of its long-term development plans.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing significant investor interest driven by strong fourth-quarter financial results, including substantial revenue growth and a strengthened balance sheet that has boosted confidence in its long-term turnaround strategy. The community is actively discussing potential catalysts such as the company's expansion into pharmaceutical manufacturing, participation in government-led reshoring initiatives, and ongoing speculation regarding its valuation as a specialized industrial and materials science player.

Dow, Inc. is a holding company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes, and construction of chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers, and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Dow Inc

Dow Inc. is trending as investors weigh significant operational restructuring, including plans for major workforce reductions, against ongoing industry-wide headwinds like weak global demand and pricing pressures. While the company is attempting to pivot toward a leaner, more productive model to unlock value, market sentiment remains cautious as traders closely monitor the stock's proximity to decade-long lows and the sustainability of its dividend payout.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results, Beats Estimates By $0.13 EPS

AngioDynamics (NASDAQ:ANGO - Get Free Report) posted its quarterly earnings results on Thursday. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.13. AngioDynamics had a negative return on equity of...

AngioDynamics Q3 Earnings Call Highlights

AngioDynamics (NASDAQ:ANGO) reported fiscal 2026 third-quarter results that management described as strong across the board, highlighted by faster growth in its MedTech segment and improved adjusted...

AngioDynamics (ANGO) Reports Q3 Loss, Tops Revenue Estimates

AngioDynamics (ANGO) delivered earnings and revenue surprises of +33.33% and +1.35%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?

AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...

Acuity, Lindsay And 3 Stocks To Watch Heading Into Thursday

U.S. stock futures trading lower, Acuity and Visionary Holdings report strong earnings, Lindsay Corp expected to post earnings, Globalstar shares jump after Amazon acquisition talks, AngioDynamics...

AngioDynamics (NASDAQ:ANGO) Downgraded to Hold Rating by Zacks Research

Zacks Research downgraded AngioDynamics from a "strong-buy" rating to a "hold" rating in a research report on Monday...

AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0%

AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 1,784,550 shares, a decline...

AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of "Moderate Buy" from Brokerages

AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five brokerages that are covering the company, Marketbeat Ratings reports. One equities...

AngioDynamics (ANGO) Expected to Announce Quarterly Earnings on Thursday

AngioDynamics (NASDAQ:ANGO) will be releasing its Q3 2026 earnings before the market opens on Thursday, April 2. (View Earnings Report at...

$ANGO Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.19 down -72.73% YoY
• Reported revenue of $78.42M up 8.91% YoY
• AngioDynamics raised its full year FY 2026 guidance for net sales to $313.5M and Adjusted EBITDA to $10M. AngioDynamics expects Med Tech net sales growth of 15%-17% and anticipates slightly negative cash flow for FY26 due to inventory build.

Stocktwits

Angiodynamic Inc

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.19 down -72.73% YoY
• Reported revenue of $78.42M up 8.91% YoY
• AngioDynamics raised its full year FY 2026 guidance for net sales to $313.5M and Adjusted EBITDA to $10M. AngioDynamics expects Med Tech net sales growth of 15%-17% and anticipates slightly negative cash flow for FY26 due to inventory build.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.08	--	--	N/A
Q3 '25	-$0.11	-$0.07	36.36%	BEAT
Q2 '25	-$0.10	$0.00	100.00%	BEAT
Q1 '25	-$0.12	-$0.10	18.32%	BEAT
Q4 '24	-$0.12	-$0.03	74.72%	BEAT

ANGO
Angiodynamic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest ANGO News

ANGOAngiodynamic Inc